Clinical usefulness of the Driver? stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era
详细信息    查看全文
  • 作者:Shinsuke Nanto (1)
    Masaki Awata (2)
    Hideki Shimomura (3)
    Takatoshi Hayashi (4)
    Shinjo Sonoda (5)
    Yoshio Ohashi (5)
    Yoshihiro Iwasaki (6)
    Hitoshi Nakashima (7)
  • 关键词:Bare metal stent ; Drug ; eluting stent ; Real ; world patient ; Target lesion revascularization ; IVUS
  • 刊名:Cardiovascular Intervention and Therapeutics
  • 出版年:2011
  • 出版时间:May 2011
  • 年:2011
  • 卷:26
  • 期:2
  • 页码:131-137
  • 全文大小:177KB
  • 参考文献:1. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schühlen H, Neumann FJ, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001;103:2816-1.
    2. Pache J, Kastrati A, Mehilli J, Schühlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41:1283-. CrossRef
    3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-3. CrossRef
    4. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-1. CrossRef
    5. Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial. EuroInterven. 2005;1:58-5.
    6. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, ENDEAVOR II Investigators, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006;114:798-06. CrossRef
    7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-02. CrossRef
    8. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108-1. CrossRef
    9. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47:175-1. CrossRef
    10. Virmani R, Guagliumi G, Farb A, Musumeci G, Greico N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-. CrossRef
    11. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-. CrossRef
    12. Saito S, Hosokawa G, Tanaka S, Nakamura S. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Interv. 1999;48:262-. CrossRef
    13. Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, MAIN-COMPARE Investigators, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167-7. CrossRef
    14. Maluenda G, Lemesle G, Ben-Dor I, Collins SD, Syed AI, Torguson R, et al. Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75:86-2.
    15. Ikari Y, Ktonari J, Kozuma K, Kyo E, Nakamura M, Yokoi H. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration—one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). Circ J. 2009;73:1038-4. CrossRef
  • 作者单位:Shinsuke Nanto (1)
    Masaki Awata (2)
    Hideki Shimomura (3)
    Takatoshi Hayashi (4)
    Shinjo Sonoda (5)
    Yoshio Ohashi (5)
    Yoshihiro Iwasaki (6)
    Hitoshi Nakashima (7)

    1. Department of Advanced Cardiovascular Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
    2. Cardiovascular Division, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
    3. Department of Cardiovascular Medicine, Fukuoka Tokushukai Medical Center, Fukuoka, Japan
    4. Department of Cardiovascular Medicine, Himeji Cardiovascular Center, Hyogo, Japan
    5. Department of Cardiology, Itabashi Chuo Medical Center, Tokyo, Japan
    6. Cardiovascular Center, Nagasaki Koseikai Hospital, Nagasaki, Japan
    7. Department of Cardiology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
文摘
The objectives of the present study were to determine predictors for target lesion revascularization (TLR) and to examine the clinical usefulness of the Driver? stent (a cobalt alloy, modular-type) in Japanese patients with coronary artery disease. Data on 631 Japanese patients including 241 with stable angina and 361 with acute coronary syndrome—who had been implanted with the Driver? stent (805 lesions) between August 2004 and February 2005—were collected retrospectively; 95.0 and 81.7% of these lesions were de novo and ACC/AHA classification B2/C type, respectively. Early angiography of 622 patients revealed 1) the preprocedural minimal lumen diameter (MLD) of 0.80?±?0.51?mm, with lesion lengths of 17.1?±?7.3?mm, and 2) the postprocedural MLD of 2.95?±?0.55?mm, with MLD gains of 2.14?±?0.68?mm. At 270?days of clinical follow-up, the incidences of major adverse cardiac events (MACE), TLR, and early stent thrombosis (ST) were 18.8, 14.7, and 0.2%, respectively; the TLR rate decreased statistically significantly to 5.3 and 5.9% when implanting the Driver? stent (3.5 and 4.0?mm) and by IVUS, respectively. Absence rate of diabetes mellitus, presence rate of AMI, presence rate of stent diameters of ?.5?mm, and presence rate of IVUS-guided PCI showed lower TLR rates, with statistically significant differences. Uni- and multivariate analyses revealed that AMI and stent diameter (?.5?mm) are significant predictors for TLR (0.048 and 0.047, respectively), indicating that physicians are recommended to consider these variables when selecting candidate real-world patients for IVUS-guided PCI.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700